-

Kirby McInerney LLP Reminds Amplitude, Inc. (AMPL) Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL) securities during the period of September 21, 2021 to February 16, 2022 inclusive (“the Class Period”). Investors have until April 15, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[Click here to learn more about the class action]

According to the complaint, Amplitude issued a press release on September 21, 2021–the same day that Amplitude announced that the registration statement for its IPO had been declared effective–announcing its financial results for its second quarter 2021. The release highlighted several metrics that purportedly showed favorable growth at the Company. On September 28, 2021, Amplitude filed with the SEC the prospectus for the IPO (“the Prospectus”). The Prospectus highlighted the Company’s land-and-expand strategy as one of its primary “Growth Strategies,” and claimed that this land-and-expand strategy was already successful. However, on February 16, 2022, Amplitude revealed its fourth quarter 2021 results and revised downward its 2022 revenue. Amplitude then stated that its land-and-expand strategy, which it had claimed had already proven successful, was in fact poised to “take a few years” before it was expected to accelerate results and that despite their prior assurances of sustainable growth, Amplitude management “really [did not] know” when this impact would occur. On this news, the price of Amplitude shares declined by $24.51 per share, or approximately 58.9%, from $41.61 on February 16, 2022 to close at $17.10 on February 17, 2022.

The lawsuit alleges that the Company's fraudulent scheme (i) deceived the investing public regarding Amplitude’s prospects and business; (ii) artificially inflated the price of Amplitude stock; and (iii) caused plaintiff and other members of the Class to purchase Amplitude stock at artificially inflated prices and suffer damages when that artificial inflation was removed from the price of Amplitude stock.

If you purchased or otherwise acquired Amplitude securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:AMPL

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 24, 2026, Culper Research published a report on ADMA alleging “Channel Stuffing, an Undisclos...

IBRX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of ImmunityBio, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities during the period of January 19, 2026 through March 24, 2026, inclusive (“the Class Period”). If you suffered a loss on your ImmunityBio investments, you have until May 26, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERE...

PYPL DEADLINE NOTICE: PayPal Holdings, Inc. Investors Encouraged to Contact Kirby McInerney LLP By April 20, 2026

NEW YORK--(BUSINESS WIRE)--If you suffered a loss on your investment inPayPal Holdings, Inc. (“PayPal” or the “Company”) (NASDAQ:PYPL), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 20, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff ove...
Back to Newsroom